Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Sweis, R. F. et al. (2026) Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies. Journal for ImmunoTherapy of Cancer, 14(7), e014638. (doi: 10.1136/jitc-2025-014638) (PMID:42476725) Text 390851.pdf - Published Version Available under License Creative Commons Attribution Non-commercial.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
